PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 142 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2018. The put-call ratio across all filers is 1.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $9,113,000 | -23.6% | 1,300,000 | 0.0% | 2.12% | -15.2% |
| Q2 2021 | $11,934,000 | -5.6% | 1,300,000 | 0.0% | 2.50% | -4.2% |
| Q1 2021 | $12,636,000 | -5.3% | 1,300,000 | 0.0% | 2.61% | +20.6% |
| Q4 2020 | $13,338,000 | +19.9% | 1,300,000 | +18.0% | 2.17% | +116.6% |
| Q3 2020 | $11,120,000 | +1052.3% | 1,102,073 | +1091.4% | 1.00% | +1198.7% |
| Q2 2020 | $965,000 | -97.2% | 92,502 | -89.7% | 0.08% | -97.8% |
| Q1 2019 | $34,911,000 | +24.3% | 900,000 | -34.8% | 3.46% | -2.6% |
| Q4 2018 | $28,077,000 | -99.9% | 1,379,700 | +175.9% | 3.55% | -29.8% |
| Q1 2018 | $34,025,000,000 | – | 500,000 | – | 5.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |